CapVest Partners LLP (“CapVest”), a leading global investment firm, has signed a definitive agreement with Bain Capital and Cinven to acquire the majority stake in STADA Arzneimittel AG “(STADA” or “the Company”), a leading healthcare and pharmaceuticals company specializing in Consumer Healthcare, Generics and Specialty pharmaceuticals. Headquartered in Bad Vilbel, Germany, STADA is a leading European pharmaceutical company focused on three strategic pillars: Consumer Healthcare, Generics and Specialty Pharmaceuticals. The company was acquired by Bain Capital and Cinven in 2017. Working with management, the two international investment firms helped transform the company from a traditional German generics business into a leading, diversified global healthcare platform.
Read the full article: CapVest to Acquire Majority Stake in STADA from Bain Capital and Cinven //
Source: https://www.businesswire.com/news/home/20250901671846/en/CapVest-to-Acquire-Majority-Stake-in-STADA-from-Bain-Capital-and-Cinven